Regeneron Pharmaceuticals, Inc.

Tarrytown, USA · 11 authors

Regeneron Pharmaceuticals, Inc. (Tarrytown, USA): 11 authors and 3 papers, and 3 patent families in the de novo peptide sequencing catalog.

Departments

  • Department of Analytical Chemistry

Authors (11)

Ankur Dhanik, Anna Rye-Weller, Darshit shah, Kamil Cygan, Olav Olsen, Qiangwei Xia, Robert Salzler, William Olson, Yuan Mao, Ning Li (Tarrytown), Thomas J. Daly

Papers (3)

Patents (3)

  • US11047863B2 Methods for de novo protein sequencing ↗ (Regeneron Pharmaceuticals, Inc., priority 2018-08-17, active)
  • US20240153587A1 Workflow to assign putative source to de novo peptide sequence ↗ (Regeneron Pharmaceuticals, Inc., priority 2021-03-11, pending)
  • US20230032607A1 Protein n-terminal de novo sequencing by position-selective dimethylation ↗ (Regeneron Pharmaceuticals, Inc., priority 2021-07-13, abandoned)

Patent families this institution was the original assignee of.

Seen in the charts

Back to the full map

Back to top